1assmann G,Echardstein A.Hypertigluceridemia and elevated lipoprotein (a) are risk factors for major coronaty events in middleged men[J].Am J Cardial,1996; 77:1179～ 1184.
5Utermann G,Kraft HG,Menzel HJ,et al.Genetics of the quantitative LP (a) lipoprotein trait; relation of qlycoprotein phenotypes to LP (a) lipoprotein concentration in plasma[J].Hum Genet,1988.78:41.
2Genest JJr, McNamara JR, Ordoras JM, et al. Prevalence of lipoprotein (a) [ Lp(a) ] excess in coronary, artery disease. Am J Cardiol, 1991 ,67 : 1039 - 1045.
3Lipid Researt:h Clinics Coronary Prevention Tria]: 1. Reduction in incidence of coronary heart disease. JAMA. 1984,251 :351 - 364.
4Soma MR,Osnago- Gadda I ,Paoletti R,et al . The Powing of lipopmtein (a) induced by estrogen plus progesterone replacement therapy in postmenopausal women. Arch Intern Med, 1993,153 : 1462 - 1468.
5Swislocki A. Insulin resistance and hypertension. Am J Med Sci, 1990,300:104-115.
6Wolfe BM, Huff MW. Effects of continuous low - dosage hormonal replacement therapy on lipopretein metabolism in postmenopausal women.Metabolism, 1995,40:410 - 417.
7Wenger NK. Postmenopausal hormone use for cardioprotection:what we know and what we must learn. Curr Opin Cardiol, 1999,14:292 -297.
5Utermann G,Kraft HG,Menzel HJ,et al.C, enetics of the quantitative LP(a) lipoprotein trait ;relation of qlyeoproteinphenotypes to LP(a) lipoprotein concentration in plasma[J].Hum Genet, 1988,78:41.
